| Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials Early Breast Cancer Trialists' Collaborative Group The Lancet 366 (9503), 2087-2106, 2005 | 5817 | 2005 |
| Effect of screening and adjuvant therapy on mortality from breast cancer DA Berry, KA Cronin, SK Plevritis, DG Fryback, L Clarke, M Zelen, ... New England Journal of Medicine 353 (17), 1784-1792, 2005 | 2856 | 2005 |
| Polychemotherapy for early breast cancer: an overview of the randomised trials Early Breast Cancer Trialists' Collaborative Group The Lancet 352 (9132), 930-942, 1998 | 2115 | 1998 |
| Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive … ML Citron, DA Berry, C Cirrincione, C Hudis, EP Winer, WJ Gradishar, ... Journal of clinical oncology 21 (8), 1431-1439, 2003 | 1975 | 2003 |
| Revision of the American Joint Committee on Cancer staging system for breast cancer SE Singletary, C Allred, P Ashley, LW Bassett, D Berry, KI Bland, ... Journal of clinical oncology 20 (17), 3628-3636, 2002 | 1720 | 2002 |
| Improved outcomes from adding sequential paclitaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast … IC Henderson, DA Berry, GD Demetri, CT Cirrincione, LJ Goldstein, ... Journal of clinical oncology 21 (6), 976-983, 2003 | 1673 | 2003 |
| Bandit problems: sequential allocation of experiments (Monographs on statistics and applied probability) DA Berry, B Fristedt London: Chapman and Hall 5 (71-87), 7-7, 1985 | 1628 | 1985 |
| Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in … AU Buzdar, NK Ibrahim, D Francis, DJ Booser, ES Thomas, RL Theriault, ... Journal of clinical oncology 23 (16), 3676-3685, 2005 | 1423 | 2005 |
| Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials JY Chang, S Senan, MA Paul, RJ Mehran, AV Louie, P Balter, HJM Groen, ... The lancet oncology 16 (6), 630-637, 2015 | 1385 | 2015 |
| Benefits and harms of CT screening for lung cancer: a systematic review PB Bach, JN Mirkin, TK Oliver, CG Azzoli, DA Berry, OW Brawley, T Byers, ... Jama 307 (22), 2418-2429, 2012 | 1368 | 2012 |
| Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial DJ Wilber, C Pappone, P Neuzil, A De Paola, F Marchlinski, A Natale, ... Jama 303 (4), 333-340, 2010 | 1346 | 2010 |
| The decrease in breast-cancer incidence in 2003 in the United States PM Ravdin, KA Cronin, N Howlader, CD Berg, RT Chlebowski, EJ Feuer, ... New England Journal of Medicine 356 (16), 1670-1674, 2007 | 1299 | 2007 |
| c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer HB Muss, AD Thor, DA Berry, T Kute, ET Liu, F Koerner, CT Cirrincione, ... New England Journal of Medicine 330 (18), 1260-1266, 1994 | 1254 | 1994 |
| Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer KS Hughes, LA Schnaper, D Berry, C Cirrincione, B McCormick, B Shank, ... New England Journal of Medicine 351 (10), 971-977, 2004 | 1118 | 2004 |
| Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343 KS Hughes, LA Schnaper, JR Bellon, CT Cirrincione, DA Berry, ... Journal of clinical oncology 31 (19), 2382, 2013 | 1043 | 2013 |
| Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer DA Berry, C Cirrincione, IC Henderson, ML Citron, DR Budman, ... Jama 295 (14), 1658-1667, 2006 | 982 | 2006 |
| Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete … WM Sikov, DA Berry, CM Perou, B Singh, CT Cirrincione, SM Tolaney, ... Journal of clinical oncology 33 (1), 13, 2015 | 951 | 2015 |
| Determining carrier probabilities for breast cancer–susceptibility genes BRCA1 and BRCA2 G Parmigiani, DA Berry, O Aguilar The American Journal of Human Genetics 62 (1), 145-158, 1998 | 852 | 1998 |
| Meta-analyses of colorectal cancer risk factors CM Johnson, C Wei, JE Ensor, DJ Smolenski, CI Amos, B Levin, DA Berry Cancer causes & control 24, 1207-1222, 2013 | 819 | 2013 |
| Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms JS Mandelblatt, KA Cronin, S Bailey, DA Berry, HJ De Koning, G Draisma, ... Annals of internal medicine 151 (10), 738-747, 2009 | 799* | 2009 |
